Besides, inhibition of MEK/ERK signaling enhances the stabilizing and protective effects of cAMP/Epac activation on endothelial cell barrier, indirectly inhibiting the progression of pulmonary fibrosis (Gündüz et al., 2019). The gene discussed is RAPGEF3; the disease is pulmonary fibrosis.